Elanco Animal Health (ELAN) Tops Q1 EPS by 2c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Elanco Animal Health Reports First Quarter Results
May 9, 2019 6:29 AM EDTGross margin (reported) improved 190 basis points to 53.0 percent of revenue Earnings per share (EPS) was $0.09 (reported), or $0.25 (adjusted) Revenue declined 1 percent to $731.1 million; Total and Core Revenue both grew 2 percent at constant currency rates Revenue from Innovation portfolio grew 59 percent, represents 13 percent of total revenue Announced agreement to acquire Aratana Therapeutics and collaboration with VetDC Expected 2019 revenue updated to be between $3.08 billion and $3.14 billion due to changes in foreign exchange rate... More
